Quarterly report pursuant to Section 13 or 15(d)

5. COMMON STOCK TRANSACTIONS (Details Narrative)

5. COMMON STOCK TRANSACTIONS (Details Narrative) - USD ($)	2 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Jul. 01, 2018	Jan. 31, 2021	Jan. 31, 2020	Jan. 31, 2021	Jan. 31, 2020	Apr. 30, 2019
Shelf Offering [Member]
Stock issued new, shares				693,000,000	137,000,000
Proceeds from sale of equity				$ 4,700,000	$ 884,000
Common Stock [Member] \| Director Letter Agreement [Member] \| Four Nonemployees [Member]
Stock issued for compensation, shares					2,000,000
Stock based compensation expense		$ 0	$ 18,988	$ 10,561	$ 46,433
Unvested shares		0	0	0	0
Common Stock [Member] \| Director Letter Agreement [Member] \| Four Nonemployee [Member]
Stock issued for compensation, shares				2,000,000
Stock based compensation expense		$ 10,411	$ 10,411	$ 26,859	$ 26,859
Unvested shares		0		0
Common Stock [Member] \| Consulting Agreement [Member] \| A Consultant [Member]
Stock issued for compensation, shares	1,200,000
Stock based compensation expense		$ 0	$ 0	$ 0	$ 12,816
Unvested shares		0	0	0	0
Common Stock [Member] \| Consulting Agreement [Member] \| A Consultant [Member]
Stock based compensation expense		$ 0	$ 0	$ 0	$ 17,350
Unvested shares		0	0	0	0
Stock to be issued for compensation, shares					500,000
Common Stock [Member] \| Consulting Agreements [Member] \| Two Consultants [Member]
Stock issued for compensation, shares						2,500,000
Stock based compensation expense		$ 0	$ 0	$ 0	$ 11,910
Unvested shares		0	0	0	0
Common Stock [Member] \| Consulting Agreements [Member] \| Four Consultants [Member]
Stock issued for compensation, shares				1,000,000
Stock based compensation expense		$ 5,409	$ 5,409	$ 15,017	$ 15,017
Unvested shares		250,000		250,000
Common Stock [Member] \| 2019 Compensation Agreement [Member] \| Officers [Member]
Stock issued for compensation, shares					6,600,000
Stock based compensation expense		$ 0	$ 69,438	$ 0	$ 278,891
Unvested shares		0	0	0	0
Common Stock [Member] \| Medical And Scientific Advisory Board [Member] \| A Consultant [Member]
Stock issued for compensation, shares					2,000,000
Stock based compensation expense		$ 0	$ 0	$ 0	$ 11,851
Unvested shares		0	0	0	0
Common Stock [Member] \| Medical And Scientific Advisory Board [Member] \| A Consultant [Member]
Stock issued for compensation, shares				500,000
Stock based compensation expense		$ 2,125	$ 0	$ 2,833	$ 0
Unvested shares		0	0	0	0
Common Stock [Member] \| 2020 Compensation Agreement [Member] \| Officers [Member]
Stock issued for compensation, shares					6,600,000
Stock based compensation expense		$ 44,881	$ 30,800	$ 179,521	$ 30,800
Unvested shares		0	6,050,000	0	6,050,000
Common Stock [Member] \| 2021 Compensation Agreement [Member] \| Executive Officer [Member]
Stock issued for compensation, shares				6,600,000
Stock based compensation expense		$ 3,685		$ 3,685
Unvested shares		6,050,000		6,050,000
Common Stock [Member] \| Four Directors [Member] \| Director Letter Agreement [Member]
Stock issued for compensation, shares					2,000,000
Stock based compensation expense		$ 0	$ 0	$ 0	$ 19,212
Unvested shares		0		0